These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28063904)

  • 1. A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques.
    Chakravarty P; Lubach JW; Hau J; Nagapudi K
    Int J Pharm; 2017 Mar; 519(1-2):44-57. PubMed ID: 28063904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry.
    Calahan JL; Azali SC; Munson EJ; Nagapudi K
    Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.
    Bansal K; Baghel US; Thakral S
    AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S; Sharma J; Munjal B; Bansal AK
    Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug.
    Mamidi HK; Rohera BD
    J Pharm Sci; 2021 Jul; 110(7):2703-2717. PubMed ID: 33609521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling as a predictive tool for the development of solid dispersions.
    Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
    Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S; Cathcart H; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
    Marsac PJ; Li T; Taylor LS
    Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
    Potter CB; Davis MT; Albadarin AB; Walker GM
    Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
    Meng F; Dave V; Chauhan H
    Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Screening for Solid Dispersions: The Trouble with Solubility Parameters and χFH.
    Turpin ER; Taresco V; Al-Hachami WA; Booth J; Treacher K; Tomasi S; Alexander C; Burley J; Laughton CA; Garnett MC
    Mol Pharm; 2018 Oct; 15(10):4654-4667. PubMed ID: 30142269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-drug interactions and wetting of solid dispersions.
    Dahlberg C; Millqvist-Fureby A; Schuleit M; Furó I
    Eur J Pharm Sci; 2010 Jan; 39(1-3):125-33. PubMed ID: 19932176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state drug-polymer miscibility studies using the model drug ABT-102.
    Jog R; Gokhale R; Burgess DJ
    Int J Pharm; 2016 Jul; 509(1-2):285-295. PubMed ID: 27265312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions.
    Mahmoudi ZN; Upadhye SB; Ferrizzi D; Rajabi-Siahboomi AR
    AAPS J; 2014 Jul; 16(4):685-97. PubMed ID: 24789531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.